Search Tag: Ortho Clinical Diagnostics

ICU Management

Maximizing the Benefits of COVID-19 Vaccines with the Right Serological Tests

2021 20 Oct

Background  Since the end of 2019, the world has been fighting the unprecedented global COVID-19 pandemic caused by SARSCoV-2. 1 This pandemic inspired significant efforts for the development of diagnostic tests, therapeutics and vaccines. 2,3,4 As a result, multiple efficacious COVID-19 vaccines have been developed and authorized in record speed5... Read more

ICU Management

Ortho Clinical Diagnostics Announces Launch of the Interleukin-6 (IL-6) Reagent Pack

2021 19 Jul

Ortho Clinical Diagnostics, one of the world’s largest pure-play in vitro diagnostics companies has announced its VITROS® Immunodiagnostic Products IL-6 Reagent Pack, the latest addition to Ortho’s VITROS® Critical Care menu, is now available in EU Countries, U.K. and several ASPAC and LATAM countries.* Results from Ortho’s IL-6 assay can be used... Read more

ICU Management

Statement From Ortho Clinical Diagnostics Regarding the Omicron Variant

2021 12 Jun

Ortho Clinical Diagnostics has been actively monitoring all 26 SARS-CoV-2 variants, including Omicron, on the potential impact to the performance of the VITROS® COVID-19 Testing Solutions including: VITROS® Anti-SARS-CoV-2 Total Assay* VITROS® Anti-SARS-CoV-2 IgG Assay* VITROS® Anti-SARS-CoV-2 IgG Quantitative Antibody Test* VITROS® SARS-CoV-2... Read more

ICU Management

Ortho’s VITROS® SARS-CoV-2 Antigen Test for High Volume COVID-19 Testing Receives CE Mark

2021 13 Apr

Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced it received CE Marking for its VITROS® SARS-CoV-2 Antigen Test, initially launched in October 2020. The CE Mark allows for more convenient sample collection and expanded viral transport media. Updates to Ortho’s COVID-19... Read more

Executive Health Management

Role of Antigen Tests in the COVID-19 pandemic

2021 17 Feb

Speakers: Dr. Karen Roush, MD, MBA Dr. Lily Li, MD, PhD, MBA Find Ortho Clinical Diagnostics - EMEA on Social Media   Read more

ICU Management

Ortho’s VITROS® B•R•A•H•M•S PCT Assay For Sepsis Now Available

2020 06 Dec

Ortho Clinical Diagnostics , a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, received CE Mark for its VITROS ®  B•R•A•H•M•S PCT (Procalcitonin) assay, now commercially available to help clinicians identify sepsis and other severe bacterial infections. Ortho’s newest assay is available... Read more

Health Management

Playing our part. How clinical laboratories can build a cleaner, more sustainable future

2020 30 Nov

An overview of the impact the healthcare industry has on the environment and how the adoption of an Environmental Management System according to ISO standards can provide a framework for a more sustainable operating model for clinical laboratories. As the healthcare industry continues to grow, so does its effect on the environment.... Read more

Executive Health Management

ORTHO Optix™ Reader Now Available in CE Mark Countries, Completes Transfusion Medicine Portfolio

2020 30 Nov

Ortho Clinical Diagnostics , a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the CE Mark availability of the semi-automated ORTHO Optix™ Reader, which allows lower-volume transfusion labs to elevate their standard of patient care with the quality of results expected... Read more

Executive Health Management

Ortho’s Next Gen TSH3 Assay to Assess Thyroid and/or Pituitary Disorders Achieves CE Mark

2020 13 Nov

Ortho Clinical Diagnostics , a global leader of in vitro diagnostics, today announced its VITROS® Immunodiagnostic Products TSH3 (Thyroid Stimulating Hormone) Reagent Pack and Calibrator has achieved CE Mark and will be commercially available in the beginning of December* to aid clinicians in assessing and diagnosing thyroid and/or pituitary gland... Read more

ICU Management

Ortho’s VITROS® COVID-19 Antigen Test Capable of Accurate Mass-Scale Testing Achieves CE Mark

2020 26 Oct

Ortho’s new SARS-CoV-2 antigen test offers 98.9% concordance to real-time PCR tests, making it a viable alternative suitable for mass-scale testing Ortho’s new SARS-CoV-2 antigen test is the latest addition to the company’s COVID-19 solutions, which include two CE Marked and FDA EUA COVID-19 antibody tests – Total and IgG Ortho Clinical... Read more